The problem we solve
Today's world depends on data, powered by AI, automation, and countless connected devices. The issue is that the networks handling this data haven't kept up. They're designed for lighter tasks not the huge, power-hungry streams we need today.
This disconnect enables organizations to collect immense volumes of data, yet they struggle to move it swiftly, reliably, or sustainably. That's where RMX steps in.
Our technology streamlines data movement and use, helping teams access real-time insights while cutting bandwidth, expenses, and energy use.
Who we work with
We partner with businesses and governments aiming to optimize digital infrastructure, from military and defense to telecoms, cloud providers, and AI companies.
We collaborate with entrepreneurs and innovators who share our vision of seamless data flows, from edge sensors to global networks.
If you're enhancing data operations, let's connect.
Management Team
Michael Chermak
Executive Chairman
Michael has over 40 years of leadership experience across healthcare, capital markets, and international business. He has raised more than $200 million for private and public companies and founded Makena Investment Advisors to support emerging organizations entering the equity markets. Michael previously built and exited Health Demographics and co-founded Medibuy.com, backed by leading venture firms. He has served on multiple public company boards and audit committees and brings extensive operational experience in both the U.S. and China.
Karl Kit
CEO
Karl has served as President, CEO, and board member of RMX since April 2025. With more than 40 years of international business experience, he has led ventures in advertising, communications, mobile data, and FinTech. Before joining RMX, Karl held leadership roles at K2 Endeavor DMCC and Omicron Holdings, working across South Africa, Europe, the U.S., and the Middle East.
Amit Shrestha
CFO
Serves as Chief Financial Officer at RMX, bringing over 20 years of global finance leadership, including a distinguished career at Microsoft. He has led digital transformation initiatives across emerging and public sector markets, notably driving sustainable growth and operational savings in Mexico, China, and the U.S. A native of Nepal, Amit holds an MBA from Seattle University and a bachelor’s degree in accounting.
Maxwell Kit
CMO
Maxwell has served as Chief Marketing Officer at RMX since April 2025. With extensive international experience in mobile technology, branding, and strategic marketing, he has led major initiatives that strengthened brand identities and expanded market reach. Before RMX, Maxwell held leadership roles at K2 Endeavor DMCC and Omicron Holdings, focusing on global marketing and FinTech strategy.
Board Members
Michael Chermak
Board Member
Michael has over 40 years of leadership experience across healthcare, capital markets, and international business. He has raised more than $200 million for private and public companies and founded Makena Investment Advisors to support emerging organizations entering the equity markets. Michael previously built and exited Health Demographics and co-founded Medibuy.com, backed by leading venture firms. He has served on multiple public company boards and audit committees and brings extensive operational experience in both the U.S. and China.
Karl Kit
CEO
Karl has served as President, CEO, and board member of RMX since April 2025. With more than 40 years of international business experience, he has led ventures in advertising, communications, mobile data, and FinTech. Before joining RMX, Karl held leadership roles at K2 Endeavor DMCC and Omicron Holdings, working across South Africa, Europe, the U.S., and the Middle East.
Steven Kirchof
Board Member – Independent
Steven Kirchof is an experienced healthcare entrepreneur and executive with over 20 years of leadership in building and scaling technology-driven healthcare companies. He is the CEO of CureGrail, Inc. and the founder of RxPath, LLC. Steven co-founded Matrix Oncology (acquired by Express Scripts) and has held senior roles at iKnowMed, MedStat Group, and IBM Healthcare. A Harvard-trained executive, he remains active in conservation and community leadership initiatives.
Richard Propper
Board Member – Independent
Richard Propper, M.D., trained at McGill (B.Sc. 1967) and Stanford (M.D. 1971), then at Harvard/Children’s and Dana-Farber, where he led blood bank/pheresis services and advanced thalassemia care. An early investor in Dean Kamen’s AutoSyringe, he founded Montgomery Medical Ventures in 1984 ($135M), backing Applied Immune Sciences, ICU Medical, and Alaris. He later led global health ventures, launched early SPACs (Origin Agritech; HollySys), and founded Tanzania’s Zariki School. He currently serves on boards focused on improving U.S. healthcare.
Ian Subel
Board Member – Independent
Ian Subel is a corporate finance executive with broad experience across technology, insurance, consumer, healthcare, waste, and energy sectors. He is Managing Director at Fogel Capital Partners and Life Models LLC. Previously, he served as CFO and Treasurer of the LifeFirms Group, Managing Director at Deloitte Corporate Finance, and Partner at Fisher Hoffman Sithole/PKF. Ian holds B.Com. and B.Acc. degrees from the University of the Witwatersrand, is a CPA, and maintains insurance licenses along with FINRA Series 7 and 63 registrations.